Detailed information for compound 227267

Basic information

Technical information
  • TDR Targets ID: 227267
  • Name: 4-(4-chlorophenyl)-4-(dimethylamino)-1-phenet hylcyclohexan-1-ol
  • MW: 357.917 | Formula: C22H28ClNO
  • H donors: 1 H acceptors: 1 LogP: 4.96 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1ccc(cc1)C1(CCC(CC1)(O)CCc1ccccc1)N(C)C
  • InChi: 1S/C22H28ClNO/c1-24(2)22(19-8-10-20(23)11-9-19)16-14-21(25,15-17-22)13-12-18-6-4-3-5-7-18/h3-11,25H,12-17H2,1-2H3
  • InChiKey: WYDMGCGGXMHGSJ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-(4-chlorophenyl)-4-(dimethylamino)-1-phenethyl-cyclohexanol
  • 4-(4-chlorophenyl)-4-(dimethylamino)-1-phenethylcyclohexanol
  • 4-(4-chlorophenyl)-4-(dimethylamino)-1-phenethyl-cyclohexan-1-ol
  • 4-(4-chlorophenyl)-4-dimethylamino-1-(2-phenylethyl)cyclohexan-1-ol
  • 4-(4-chlorophenyl)-4-dimethylamino-1-(2-phenylethyl)-1-cyclohexanol

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma brucei DNA polymerase kappa, putative 0.0035 0.0454 0.3223
Schistosoma mansoni transcription factor LCR-F1 0.004 0.0565 0.4172
Trypanosoma cruzi tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0074 0.1247 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0046 0.0681 0.516
Entamoeba histolytica tyrosyl-DNA phosphodiesterase, putative 0.0074 0.1247 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.0681 0.516
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.0681 0.516
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.0681 0.516
Entamoeba histolytica hypothetical protein 0.004 0.0565 0.4172
Schistosoma mansoni hypothetical protein 0.0058 0.0923 0.7227
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.0024 0.0227 0.0151
Mycobacterium tuberculosis Probable isocitrate lyase AceAb [second part] (isocitrase) (isocitratase) (Icl) 0.0507 1 1
Leishmania major DNA polymerase kappa, putative 0.0024 0.0227 0.128
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.0681 0.516
Trypanosoma brucei unspecified product 0.0039 0.0531 0.3879
Entamoeba histolytica hypothetical protein 0.004 0.0565 0.4172
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.0681 0.516
Trypanosoma brucei DNA polymerase kappa, putative 0.0024 0.0227 0.128
Trichomonas vaginalis DNA polymerase eta, putative 0.0046 0.0681 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.0681 0.516
Echinococcus multilocularis tyrosyl DNA phosphodiesterase 1 0.0074 0.1247 1
Trypanosoma brucei DNA polymerase IV, putative 0.0046 0.0681 0.516
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.0681 0.516
Toxoplasma gondii BRCA1 C Terminus (BRCT) domain-containing protein 0.0012 0 0.5
Mycobacterium ulcerans isocitrate lyase AceAb 0.0507 1 1
Loa Loa (eye worm) hypothetical protein 0.0035 0.0454 0.3223
Trypanosoma brucei DNA polymerase IV, putative 0.0046 0.0681 0.516
Entamoeba histolytica hypothetical protein 0.004 0.0565 0.4172
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0125 0.0408
Trypanosoma cruzi tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0074 0.1247 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0035 0.0454 0.3223
Trypanosoma cruzi DNA polymerase kappa, putative 0.0046 0.0681 0.516
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0046 0.0681 0.5
Echinococcus granulosus transcription factor Dp 1 0.0043 0.0616 0.4606
Giardia lamblia DINP protein human, muc B family 0.0024 0.0227 0.5
Mycobacterium ulcerans isocitrate lyase Icl 0.0507 1 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0046 0.0681 0.516
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.0681 0.516
Trypanosoma brucei tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0074 0.1247 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.0681 0.516
Mycobacterium tuberculosis Isocitrate lyase Icl (isocitrase) (isocitratase) 0.0507 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0125 0.0408
Mycobacterium tuberculosis Probable isocitrate lyase AceAa [first part] (isocitrase) (isocitratase) (Icl) 0.0507 1 1
Brugia malayi Tyrosyl-DNA phosphodiesterase family protein 0.0074 0.1247 1
Schistosoma mansoni hypothetical protein 0.004 0.0565 0.4172
Brugia malayi polk-prov protein 0.0035 0.0454 0.3223
Entamoeba histolytica hypothetical protein 0.004 0.0565 0.4172
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0125 0.0408
Leishmania major tyrosyl-DNA phosphodiesterase 1 0.0074 0.1247 1
Echinococcus multilocularis dna polymerase kappa 0.0046 0.0681 0.516
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.004 0.0565 0.4172
Echinococcus granulosus dna polymerase kappa 0.0046 0.0681 0.516
Echinococcus granulosus tyrosyl DNA phosphodiesterase 1 0.0074 0.1247 1
Brugia malayi hypothetical protein 0.004 0.0565 0.4172
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.004 0.0565 0.4172
Echinococcus multilocularis transcription factor Dp 1 0.0043 0.0616 0.4606
Loa Loa (eye worm) tyrosyl-DNA phosphodiesterase 0.0074 0.1247 1
Schistosoma mansoni tyrosyl-DNA phosphodiesterase 0.0074 0.1247 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0046 0.0681 0.516
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0024 0.0227 0.128
Trypanosoma brucei DNA polymerase IV, putative 0.0039 0.0531 0.3879

Activities

Activity type Activity value Assay description Source Reference
ED50 (functional) = 0.0014 mg kg-1 Analgesic activity (ED50) using tail-flick assay in mice ChEMBL. 7265128
ED50 (functional) = 0.0014 mg kg-1 Analgesic activity (ED50) using tail-pinch assay in mice ChEMBL. 7265128
ED50 (functional) = 0.0014 mg kg-1 Analgesic activity (ED50) using tail-flick assay in mice ChEMBL. 7265128
ED50 (functional) = 0.0014 mg kg-1 Analgesic activity (ED50) using tail-pinch assay in mice ChEMBL. 7265128
ED50 (functional) = 0.0018 mg kg-1 Analgesic activity (ED50) measured using HCl writhing assay in mice ChEMBL. 7265128
ED50 (functional) = 0.0018 mg kg-1 Analgesic activity (ED50) measured using HCl writhing assay in mice ChEMBL. 7265128
ED50 (functional) = 0.1 mg kg-1 Analgesic activity (ED50) using inclined screen assay in mice ChEMBL. 7265128
ED50 (functional) = 0.1 mg kg-1 Analgesic activity (ED50) using inclined screen assay in mice ChEMBL. 7265128
ED50 (functional) = 56 mg kg-1 Analgesic activity (ED50) measured using HCl writhing assay in mice ChEMBL. 7265128
ED50 (functional) = 56 mg kg-1 Analgesic activity (ED50) measured using HCl writhing assay in mice ChEMBL. 7265128
ED50 (functional) > 100 mg kg-1 Analgesic activity (ED50) using tail-flick assay in mice ChEMBL. 7265128
ED50 (functional) > 100 mg kg-1 Analgesic activity (ED50) using tail-pinch assay in mice ChEMBL. 7265128
ED50 (functional) > 100 mg kg-1 Analgesic activity (ED50) using inclined screen assay in mice ChEMBL. 7265128
ED50 (functional) > 100 mg kg-1 Blockade of morphine-induced elevation of tail-flick latency ChEMBL. 7265128
ED50 (functional) > 100 mg kg-1 Analgesic activity (ED50) using tail-flick assay in mice ChEMBL. 7265128
ED50 (functional) > 100 mg kg-1 Analgesic activity (ED50) using tail-pinch assay in mice ChEMBL. 7265128
ED50 (functional) > 100 mg kg-1 Analgesic activity (ED50) using inclined screen assay in mice ChEMBL. 7265128
ED50 (functional) > 100 mg kg-1 Blockade of morphine-induced elevation of tail-flick latency ChEMBL. 7265128

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.